In conclusion, the present study provided novel insights that SSYX may exert anti-arrhythmia effect via increased Ito, ICa-L, and Cx43 expression through regulating TLR4/MyD88/CaMKII signaling pathway, which may be the mechanism of electrical remodeling MetS-induced VA. This evidence concerns the gene TLR4 and metabolic syndrome.